NasdaqCM - Delayed Quote • USD
XORTX Therapeutics Inc. (XRTX)
At close: April 26 at 4:00 PM EDT
After hours: April 26 at 7:35 PM EDT
Breakdown
TTM
12/31/2022
12/31/2021
12/31/2020
Operating Expense
7,293.8359
9,862.2539
2,862.3261
1,019.8744
Operating Income
-7,293.8359
-9,862.2539
-2,862.3261
-1,019.8744
Net Non Operating Interest Income Expense
255.2218
101.3668
-4.3905
-10.5963
Other Income Expense
332.1433
2,772.0063
1,570.8295
23.0661
Pretax Income
-6,706.4708
-6,988.8808
-1,295.8871
-1,007.4046
Net Income Common Stockholders
-6,706.4708
-6,988.8808
-1,295.8871
-1,007.4046
Diluted NI Available to Com Stockholders
-6,706.4708
-6,988.8808
-1,295.8871
-1,007.4046
Basic EPS
-3.60
-4.71
-1.20
-1.34
Diluted EPS
-3.60
-4.71
-1.20
-1.34
Basic Average Shares
1,879.4620
1,479.9130
1,094.1820
740.4470
Diluted Average Shares
1,879.4620
1,479.9130
1,094.1820
740.4470
Total Expenses
7,293.8359
9,862.2539
2,862.3261
1,019.8744
Net Income from Continuing & Discontinued Operation
-6,706.4708
-6,988.8808
-1,295.8871
-1,007.4046
Normalized Income
-7,038.6141
-9,760.8871
-2,866.7166
-1,030.4707
Interest Income
255.2218
101.3668
--
--
Interest Expense
--
--
4.3905
10.5963
Net Interest Income
255.2218
101.3668
-4.3905
-10.5963
EBIT
-4,420.4628
-6,988.8808
-1,291.4966
-996.8082
EBITDA
-4,285.2595
-6,933.4225
-1,277.4717
-980.7797
Reconciled Depreciation
135.2033
55.4583
14.0249
16.0286
Net Income from Continuing Operation Net Minority Interest
-6,706.4708
-6,988.8808
-1,295.8871
-1,007.4046
Total Unusual Items Excluding Goodwill
332.1433
2,772.0063
1,570.8295
23.0661
Total Unusual Items
332.1433
2,772.0063
1,570.8295
23.0661
Normalized EBITDA
-4,617.4028
-9,705.4288
-2,848.3012
-1,003.8458
12/31/2020 - 9/23/2021
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
SVA.TO Sernova Corp.
0.4400
+3.53%
MTEM Molecular Templates, Inc.
1.7050
+7.23%
NRXS NeurAxis, Inc.
3.2500
+8.33%
EVAX Evaxion Biotech A/S
4.1800
+1.46%
VRPX Virpax Pharmaceuticals, Inc.
3.1000
+8.01%
IMRN Immuron Limited
2.6400
+6.02%
NEXI NexImmune, Inc.
3.3700
-1.17%
IPHA Innate Pharma S.A.
2.4600
+2.50%
AGN.CN Algernon Pharmaceuticals Inc.
0.1300
+8.33%
HOTH Hoth Therapeutics, Inc.
1.1600
0.00%